Physician profile
Robert Stahlkuppe
NPI 1356440853
$596.08
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.02 · 2020: $58.99 · 2021: $215 · 2022: $50.30 · 2023: $96.86 · 2024: $77.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $174.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $220.94 | 2021-2024 | Vraylar |
| Sunovion Pharmaceuticals INC. | $129.35 | 2019-2022 | |
| Lilly USA, LLC | $52.20 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $37.10 | 2023 | Rexulti |
| Exact Sciences Corporation | $31.61 | 2024 | Cologuard Collection Kit |
| Dexcom, INC. | $31.16 | 2024 | Dexcom G6 Transmitter |
| Mylan Specialty L.P. | $21.76 | 2021 | |
| Amgen INC. | $17.79 | 2022 | |
| Glaxosmithkline, LLC. | $16.14 | 2020 | |
| Eisai INC. | $13.52 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.71 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Stahlkuppe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.